Taysha Gene Therapies (NASDAQ:TSHA) Earns Market Outperform Rating from JMP Securities
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “market outperform” rating restated by investment analysts at JMP Securities in a research note issued on Monday,Benzinga reports. They presently have a $5.00 price target on the stock. JMP Securities’ target price would indicate a potential upside of 174.73% from the company’s previous close. […]
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “market outperform” rating restated by investment analysts at JMP Securities in a research note issued on Monday,Benzinga reports. They presently have a $5.00 price target on the stock. JMP Securities’ target price would indicate a potential upside of 174.73% from the company’s previous close. […]
